Characteristics of the 86 hospitalized patients with COVID-19 and VTE
| Characteristics | Data |
| Age, mean; SD | 61; 15.4 |
| Male sex, n (%) | 42 (48) |
| Active cancer,* n (%) | 3 (3.4) |
| INR >1.5 during admission,† n (%) | 4 (4.6) |
| Renal replacement therapy during admission, n (%) | 26 (30.2) |
| Peak D-dimer, median (IQR), μg/mL | 7.59 (3.07-32.24) |
| Mechanical ventilation, n (%) | 45 (52.3) |
| High risk, by Padua score, n (%) | 77 (89) |
| Low risk, by Padua score, n (%) | 9 (11) |
| Characteristics | Data |
| Age, mean; SD | 61; 15.4 |
| Male sex, n (%) | 42 (48) |
| Active cancer,* n (%) | 3 (3.4) |
| INR >1.5 during admission,† n (%) | 4 (4.6) |
| Renal replacement therapy during admission, n (%) | 26 (30.2) |
| Peak D-dimer, median (IQR), μg/mL | 7.59 (3.07-32.24) |
| Mechanical ventilation, n (%) | 45 (52.3) |
| High risk, by Padua score, n (%) | 77 (89) |
| Low risk, by Padua score, n (%) | 9 (11) |
INR, international normalized ratio; IQR, interquartile range; SD, standard deviation.
*Received at least 1 treatment of cancer (radiation, chemotherapy, or surgery) in prior 12 mo.
†Coagulopathy was defined as INR >1.5 prior to anticoagulation.